Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : paclitaxel
  • Topics : Genital cancers
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Drug therapy (1)
    • Radiotherapy and physical agents (1)
    • Surgical procedures (1)
    • Plus ...
      • Gastrointestinal surgery (1)
      • Urogenital surgery (1)
  • Diseases and conditions (2)
  • Plus ...
    • Genital diseases (2)
    • Plus ...
      • Genital cancers (2)
    • Digestive system diseases (1)
    • Plus ...
      • Digestive system cancers (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Health technology assessment (2)
Date
  • Last five years (1)
Manufacturer
  • industriels (1)
Language
  • Français (2)
Active substance
  • acide folinique (1)
  • alcool (1)
  • carboplatine (2)
  • cisplatine (2)
  • fluorouracile (1)
  • gemcitabine (1)
  • morphine (1)
  • oxaliplatine (1)
  • paclitaxel (2)
  • thiosulfate de sodium (1)
 More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC) associated or not with prior cytoreductive surgery - INAHTA Brief

    Health technology assessment - Posted on 21/6/2021
    Download document
    Add to my selection

  • Conformational intensity-modulated radiation therapy in cervical cancer

    Health technology assessment - Posted on 17/3/2015
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
GFFBykYCBxNDwPZt